tetano
Editor, Senior Moderator
J Virol
. 2023 Aug 21;e0079023.
doi: 10.1128/jvi.00790-23. Online ahead of print. Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus
Hao-Feng Lin[SUP] #[/SUP][SUP] 1 2 [/SUP], Mei-Qin Liu[SUP] #[/SUP][SUP] 1 2 [/SUP], Ren-Di Jiang[SUP] #[/SUP][SUP] 1 3 [/SUP], Qian-Chun Gong[SUP] 3 [/SUP], Jia Su[SUP] 1 2 [/SUP], Zi-Shuo Guo[SUP] 1 2 [/SUP], Ying Chen[SUP] 1 2 [/SUP], Jing-Kun Jia[SUP] 1 2 [/SUP], Tian-Yi Dong[SUP] 1 2 [/SUP], Yan Zhu[SUP] 1 [/SUP], Ang Li[SUP] 1 2 [/SUP], Xu-Rui Shen[SUP] 4 [/SUP], Yi Wang[SUP] 1 [/SUP], Bei Li[SUP] 1 [/SUP], Ting-Ting Xie[SUP] 1 2 [/SUP], Xing-Lou Yang[SUP] 1 [/SUP], Ben Hu[SUP] 1 [/SUP], Zheng-Li Shi[SUP] 1 [/SUP]
Affiliations
Bats carry genetically diverse severe acute respiratory syndrome-related coronaviruses (SARSr-CoVs). Some of them utilize human angiotensin-converting enzyme 2 (hACE2) as a receptor and cannot efficiently replicate in wild-type mice. Our previous study demonstrated that the bat SARSr-CoV rRsSHC014S induces respiratory infection and lung damage in hACE2 transgenic mice but not wild-type mice. In this study, we generated a mouse-adapted strain of rRsSHC014S, which we named SMA1901, by serial passaging of wild-type virus in BALB/c mice. SMA1901 showed increased infectivity in mouse lungs and induced interstitial lung pneumonia in both young and aged mice after intranasal inoculation. Genome sequencing revealed mutations in not only the spike protein but the whole genome, which may be responsible for the enhanced pathogenicity of SMA1901 in wild-type BALB/c mice. SMA1901 induced age-related mortality similar to that observed in SARS and COVID-19. Drug testing using antibodies and antiviral molecules indicated that this mouse-adapted virus strain can be used to test prophylactic and therapeutic drug candidates against SARSr-CoVs. IMPORTANCE The genetic diversity of SARSr-CoVs in wildlife and their potential risk of cross-species infection highlights the importance of developing a powerful animal model to evaluate the antibodies and antiviral drugs. We acquired the mouse-adapted strain of a bat-origin coronavirus named SMA1901 by natural serial passaging of rRsSHC014S in BALB/c mice. The SMA1901 infection caused interstitial pneumonia and inflammatory immune responses in both young and aged BALB/c mice after intranasal inoculation. Our model exhibited age-related mortality similar to SARS and COVID-19. Therefore, our model will be of high value for investigating the pathogenesis of bat SARSr-CoVs and could serve as a prospective test platform for prophylactic and therapeutic candidates.
Keywords: animal model; bat SARS-related coronavirus; mouse-adapted strain; pathogenicity; pneumonia.
. 2023 Aug 21;e0079023.
doi: 10.1128/jvi.00790-23. Online ahead of print. Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus
Hao-Feng Lin[SUP] #[/SUP][SUP] 1 2 [/SUP], Mei-Qin Liu[SUP] #[/SUP][SUP] 1 2 [/SUP], Ren-Di Jiang[SUP] #[/SUP][SUP] 1 3 [/SUP], Qian-Chun Gong[SUP] 3 [/SUP], Jia Su[SUP] 1 2 [/SUP], Zi-Shuo Guo[SUP] 1 2 [/SUP], Ying Chen[SUP] 1 2 [/SUP], Jing-Kun Jia[SUP] 1 2 [/SUP], Tian-Yi Dong[SUP] 1 2 [/SUP], Yan Zhu[SUP] 1 [/SUP], Ang Li[SUP] 1 2 [/SUP], Xu-Rui Shen[SUP] 4 [/SUP], Yi Wang[SUP] 1 [/SUP], Bei Li[SUP] 1 [/SUP], Ting-Ting Xie[SUP] 1 2 [/SUP], Xing-Lou Yang[SUP] 1 [/SUP], Ben Hu[SUP] 1 [/SUP], Zheng-Li Shi[SUP] 1 [/SUP]
Affiliations
- PMID: 37607058
- DOI: 10.1128/jvi.00790-23
Bats carry genetically diverse severe acute respiratory syndrome-related coronaviruses (SARSr-CoVs). Some of them utilize human angiotensin-converting enzyme 2 (hACE2) as a receptor and cannot efficiently replicate in wild-type mice. Our previous study demonstrated that the bat SARSr-CoV rRsSHC014S induces respiratory infection and lung damage in hACE2 transgenic mice but not wild-type mice. In this study, we generated a mouse-adapted strain of rRsSHC014S, which we named SMA1901, by serial passaging of wild-type virus in BALB/c mice. SMA1901 showed increased infectivity in mouse lungs and induced interstitial lung pneumonia in both young and aged mice after intranasal inoculation. Genome sequencing revealed mutations in not only the spike protein but the whole genome, which may be responsible for the enhanced pathogenicity of SMA1901 in wild-type BALB/c mice. SMA1901 induced age-related mortality similar to that observed in SARS and COVID-19. Drug testing using antibodies and antiviral molecules indicated that this mouse-adapted virus strain can be used to test prophylactic and therapeutic drug candidates against SARSr-CoVs. IMPORTANCE The genetic diversity of SARSr-CoVs in wildlife and their potential risk of cross-species infection highlights the importance of developing a powerful animal model to evaluate the antibodies and antiviral drugs. We acquired the mouse-adapted strain of a bat-origin coronavirus named SMA1901 by natural serial passaging of rRsSHC014S in BALB/c mice. The SMA1901 infection caused interstitial pneumonia and inflammatory immune responses in both young and aged BALB/c mice after intranasal inoculation. Our model exhibited age-related mortality similar to SARS and COVID-19. Therefore, our model will be of high value for investigating the pathogenesis of bat SARSr-CoVs and could serve as a prospective test platform for prophylactic and therapeutic candidates.
Keywords: animal model; bat SARS-related coronavirus; mouse-adapted strain; pathogenicity; pneumonia.